Aborode Abdullahi Tunde, Olotu Titilayo Mabel, Oyetunde O B, Ajagbe Abayomi Oyeyemi, Mustapha Mariam Ayoola, Karra-Aly Ayah, Oko Christian Inya
Healthy African Platform, Research and Development, Ibadan, Nigeria.
Student Against COVID-19, Research and Education, USA.
Ann Med Surg (Lond). 2022 May 16;78:103768. doi: 10.1016/j.amsu.2022.103768. eCollection 2022 Jun.
The effect of COVID-19 is enormous, and high-risk COVID-19 case arises when underlying infections like diabetes, chronic obstructive pulmonary disease, heart failure, coronary artery disease, or cardiomyopathy are present, and an immunocompromised state such as Human Immunodeficiency Virus (HIV). People living with HIV(PLHIV) may be exposed to severe COVID-19, mostly in areas with poor access to proper care and complex intervention for HIV infection. During the lockdown, those with medical appointments will not access health facilities, which may be detrimental to people living with HIV. Emerging evidence suggests COVID-19 pandemic fear may lead to adverse mental health outcomes and affect preventive behavior. In addition to the stigma and discrimination associated with HIV, COVID-19 is also causing concerns. People with HIV tend to have mental health issues such as depression, anxiety, and post-traumatic stress (PTSD), which can be both a cause and a harmful impact of HIV. Discussed in this research is the effect of the COVID-19 pandemic on HIV patients, their similarities, differences, and urgent attention from healthcare centers to take charge and respond to patients with HIV and other immunosuppressed conditions during the COVID-19 pandemic.
新型冠状病毒肺炎（COVID-19）的影响巨大，当存在如糖尿病、慢性阻塞性肺疾病、心力衰竭、冠状动脉疾病或心肌病等基础感染，以及处于免疫功能低下状态如人类免疫缺陷病毒（HIV）感染时，就会出现COVID-19高风险病例。感染HIV的人（PLHIV）可能会感染严重的COVID-19，这种情况大多发生在难以获得针对HIV感染的适当治疗和综合干预措施的地区。在封锁期间，那些有医疗预约的人将无法前往医疗机构，这可能对感染HIV的人不利。新出现的证据表明，对COVID-19大流行的恐惧可能导致不良心理健康后果并影响预防行为。除了与HIV相关的耻辱和歧视外，COVID-19也引发了人们的担忧。感染HIV的人往往存在心理健康问题，如抑郁、焦虑和创伤后应激障碍（PTSD），这些问题既是HIV感染的原因，也是其有害影响。本研究讨论了COVID-19大流行对HIV患者的影响、他们的异同，以及医疗中心在COVID-19大流行期间对HIV患者和其他免疫抑制状况患者进行管理和应对时应给予的紧急关注。
